Abstract
Background
Patients with primary hyperparathyroidism (pHPT) and a negative preoperative Tc-99 sestamibi (MIBI) scintigraphy are considered to have a higher risk of persistent disease. The aim of this study was to assess whether additional imaging with C-11 methionine positron emission tomography/computed tomography (Met-PET/CT) is able to localise sestamibi-negative hyperfunctioning parathyroid glands.
Methods
In 50 patients (38 females, 12 males, age 13–81 years) with pHPT and negative localisation procedures such as ultrasound and sestamibi, a Met-PET/CT was performed before parathyroid surgery. The results of Met-PET/CT were analysed prospectively and compared with intraoperative and histopathological findings. 22% of the patients underwent previous parathyroid and/or thyroid surgery.
Results
Met-PET/CT correctly located a single-gland adenoma in 33 of 45 (73%) patients with pHPT. In 5 patients with multiglandular disease, Met-PET/CT detected at least one hyperfunctional parathyroid gland in 4 patients (80%). In 3 patients with double adenomas, 5 of 6 parathyroids were correctly located. Overall, 40 of 57 (70%) hyperfunctioning glands were identified with Met-PET/CT. Met-PET/CT was false-negative in 12 of 50 (24%) patients and false-positive in only one case (2%). Postoperatively, 48 of 50 patients (96%) were cured.
Conclusions
Additional pre-interventional imaging with Met-PET/CT was able to identify hyperfunctioning parathyroid glands in 74% of patients with pHPT and negative sestamibi scans, thus enabling successful parathyroid surgery.
Similar content being viewed by others
References
Bergenfelz AO, Hellman P, Harrison B, Sitges-Serra A, Dralle H (2009) Positional statement of the European Society of Endocrine Surgeons (ESES) on modern techniques in pHPT surgery. Langenbecks Arch Surg 394:761–764
Elaraj DM, Sippel RS, Lindsay S, Sansano I, Duh Q-Y, Clark OH, Kebebew E (2010) Are additional localization studies and referral indicated for patients with primary hyperparathyroidism who have negative sestamibi scan results? Arch Surg 145:578–581
Bergenfelz AOJ, Wallin G, Jansson S, Eriksson H, Martensson H, Christiansen P, Reihner E (2012) Results of surgery for sporadic primary hyperparathyroidism in patients with preoperatively negative sestamibi scintigraphy and ultrasound. Langenbecks Arch Surg 396:83–90
Dy BM, Richards ML, Vazquez BJ, Thompson GB, Farley DR, Grant CS (2012) Primary hyperparathyroidism and negative Tc99 sestamibi imaging: to operate or not? Ann Surg Oncol 19:2272–2278
Hellman P, Ahlström H, Bergström M, Sundin A, Langström B, Westerberg G, Juhlin C, Akerström G, Rastad J (1994) Positron emission tomography with 11C-methionine in hyperparathyroidism. Surgery 116:974–981
Sundin A, Johansson C, Hellman P, Bergström M, Ahlström H, Jacobson GB, Langström B, Rastad J (1996) PET and parathyroid L-[carbon-11]methionine accumulation in hyperparathyroidism. J Nucl Med 37:1766–1770
Cook GJR, Wong JCH, Smellie WJB, Young AE, Maisey MN, Fogelman I (1998) [11C] Methionine positron emission tomography for patients with persistent or recurrent hyperparathyroidism after surgery. Eur J Endocrinol 139:195–197
Hessman O, Stalberg P, Sundin A, Garske U, Rudberg C, Eriksson L-G, Akerström G (2008) High success rate of parathyroid reoperation may be achieved with improved localization diagnosis. World J Surg 32:774–781. doi:10.1007/s00268-008-9537-5
Tang B-N-T, Moreno-Reyes R, Blocklet D, Corvilain B, Cappello M, Delpierre I, Devuyst F, Van Simaeys G, Goldman S (2008) Accurate pre-operative localization of pathological parathyroid glands using 11C-methionine PET/CT. Contrast Media Mol Imaging 3:157–163
Weber T, Cammerer G, Schick C, Solbach C, Hillenbrand A, Barth TF, Henne-Bruns D, Blagieva R, Böhm BO, Reske SN, Luster M (2010) C-11 methionine positron emission tomography/computed tomography localizes parathyroid adenomas in primary hyperparathyroidism. Horm Metab Res 42:209–214
Weber T, Maier-Funk C, Ohlhauser D, Hillenbrand A, Cammerer G, Barth TF, Henne-Bruns D, Boehm BO, Reske SN, Luster M (2013) Accurate preoperative localization of parathyroid adenomas with C-11 methionine PET/CT. Ann Surg 257:1124–1128
Chun IK, Cheon GJ, Paeng JC, Kang KW, Chung JK, Lee DS (2013) Detection and Characterization of parathyroid adenoma/hyperplasia for preoperative localization: comparison between (11)C—methionine PET/CT and (99 m)Tc-sestamibi scintigraphy. Nucl Med Mol Imaging 47:166–172
Traub-Weidinger T, Mayerhoefer ME, Koperek O, Mitterhauser M, Duan H, Karanikas G, Niederle B, Hoffmann M (2014) 11C-methionine PET/CT imaging of 99mTc-MIBI-SPECT/CT negative patients with primary hyperparathyroidism and previous neck surgery. JCEM 99:4199–4205
Bergenfelz AO, Jansson SK, Wallin GK, Martenson HG, Rasmussen L, Eriksson HL, Reihnér EI (2009) Impact of modern techniques on short-term outcome after surgery for primary hyperparathyroidism: a multicentre study comprising 2708 patients. Langenbecks Arch Surg 394:851–860
Bagul A, Patel HP, Chadwick D, Harrison BJ, Balasubramanian SP (2014) Primary hyperparathyroidism: an analysis of failure of parathyroidectomy. World J Surg 38:534–541. doi:10.1007/s00268-013-2434-6
Schalin-Jäntti C, Ryhänen E, Heiskanen I, Seppänen M, Arola J, Schildt J, Väisänen M, Nelimarkka L, Lisinen I, Aalto V, Nuutila P, Välimäki MJ (2013) Planar scintigraphy with 123I/99mTc-sestamibi, 99mTc-sestamibi SPECT/CT, 11C-methionine PET/CT, or selective venous sampling before reoperation of primary hyperparathyroidism? J Nucl Med 54:739–747
Schmidt M, Kahraman D, Neumaier B, Ortmann M, Stippel D (2011) Tc-99 m-MIBI-negative parathyroid adenoma in primary hyperparathyroidism detected by C-11-methionine PET/CT after previous thyroid surgery. Clin Nucl Med 36:1153–1155
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Weber, T., Gottstein, M., Schwenzer, S. et al. Is C-11 Methionine PET/CT Able to Localise Sestamibi-Negative Parathyroid Adenomas?. World J Surg 41, 980–985 (2017). https://doi.org/10.1007/s00268-016-3795-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-016-3795-4